Last updated: April 26, 2026
What does KR20220113436 cover and how broad are its claims in South Korea?
KR20220113436 is a South Korea (Korean-language) patent application publication. The available prompt does not include the publication text, claims, assignee, title, filing date, priority data, IPC/CPC classes, or prosecution history. Without the actual claim set and bibliographic/legal record, a complete and accurate scope-and-claims analysis and a KR landscape map cannot be produced.
What is the claim scope for KR20220113436?
No claim text or claim numbering is provided for KR20220113436. Without the published claims, any attempt to describe claim breadth (independent claim coverage, dependent claim delimitations, Markush structures, composition vs method-of-use coverage, dosage forms, specificity of targets, and enabling disclosures) would be non-compliant with the requirement to deliver a complete and accurate response.
How does KR20220113436 sit in the South Korea patent landscape for its drug?
A landscape analysis requires, at minimum, the drug identity (INN), active moiety, and relevant claim topics, then a South Korea-focused search across:
- family members (WO/EP/US filings tied to the same priority),
- KR granted/registered counterparts,
- co-pending KR applications by the same and competing applicants,
- relevant patent term adjustments (if any), and
- formal status (published, pending, granted, lapsed, withdrawn) for each close family member.
None of these inputs are present in the prompt, so the landscape cannot be built.
Key Takeaways
- KR20220113436 scope and claim breadth cannot be analyzed without the published claims and bibliographic record.
- A South Korea drug patent landscape cannot be mapped without identifying the drug/active moiety covered by KR20220113436 and its patent family.
- No actionable freedom-to-operate or competitive positioning conclusions can be produced from the information provided.
FAQs
-
Can you outline the independent claims of KR20220113436?
Not with the information provided. The claim text is not included.
-
Does KR20220113436 cover composition, method-of-use, or manufacturing?
Not determinable from the prompt because no claim categories or claim wording is provided.
-
What is KR20220113436’s priority date and family scope?
Not determinable because no bibliographic or family data is provided.
-
Which South Korea patents are likely closest to KR20220113436?
Not determinable because the covered drug/active moiety is not identified.
-
Can you produce an enforceability view (granted vs pending) in KR?
Not determinable because the legal status in Korea is not provided.
Sources
[1] No source material was provided in the prompt (no KR20220113436 publication text, claims, bibliographic data, or legal status record).
